We cannot predict the ultimate content, timing or effect of any changes to the ACA, the Inflation Reduction Act, or other federal and state healthcare policy reform efforts including those aimed at drug pricing. There is no assurance that federal or state health care reform will not adversely affect our future business and financial results, and we cannot predict how future federal or state legislative, judicial or administrative changes relating to healthcare policy will affect our business.
All entries for: Inc
April 29, 2025
Inc
Negative Outlook
Disease Area: Cardiology, Infectious Diseases, Multiple
Drug Type: Biologic, Small Molecule